CFO transition
Co-Diagnostics, Inc. CFO transition: Daniel Bohrer to succeed Brian Brown
Co-Diagnostics, Inc. reported in a Form 8-K filed September 4, 2026 that Daniel Bohrer will succeed Brian Brown as principal financial officer and principal accounting officer, effective September 2, 2026.
In the filing's words
Effective as of the Separation Date, Daniel Bohrer, the Company’s Executive Vice President of Finance and Accounting, will serve as the Company’s principal financial officer and principal accounting officer.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Co-Diagnostics, Inc. (CODX) |
|---|---|
| Event | Transition |
| Incoming | Daniel Bohrer |
| Outgoing | Brian Brown |
| Title in the filing | principal financial officer and principal accounting officer |
| Effective | September 2, 2026 |
| 8-K filed | September 4, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Executive Vice President of Finance and Accounting, Co-Diagnostics, Inc. |
| SEC CIK | 0001692415 |
Co-Diagnostics, Inc. reported this change in a Form 8-K, Item 5.02, filed September 4, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Daniel Bohrer? Send a correction with the primary source.